Literature DB >> 17445292

Linguistic changes in verbal expression: a preclinical marker of Alzheimer's disease.

Fernando Cuetos1, Juan Carlos Arango-Lasprilla, Claramónika Uribe, Claudia Valencia, Francisco Lopera.   

Abstract

Despite the many studies examining linguistic deterioration in Alzheimer's disease (AD), very little is known about changes in verbal expression during the preclinical phase of this disease. The objective of this study was to determine whether changes in verbal expression occur in the preclinical phase of AD. The sample consisted of 40 healthy Spanish speakers from Antioquia, Colombia. A total of 19 were carriers of the E280A mutation in the Presenilin 1 gene, and 21 were noncarrier family members. The two groups were similar in age and education. All the participants were shown the Cookie Theft Picture Card from the Boston Diagnostic Aphasia Examination and were asked to describe the scene. Specific grammatical and semantic variables were evaluated. The performance of each group was compared using multivariate analyses of the variance for semantic and grammatical variables, and errors. Carriers of the mutation produced fewer semantic categories than noncarriers. In the preclinical phase of AD, changes in verbal expression are apparent and early detection of these differences may assist the early diagnosis of and intervention in this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445292     DOI: 10.1017/S1355617707070609

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  19 in total

1.  Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Authors:  Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Paul E Gilbert; Li-Jung Liang; Jeffrey L Cummings; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-08-30       Impact factor: 2.959

2.  Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.

Authors:  Christina E Wierenga; Nikki H Stricker; Ashley McCauley; Alan Simmons; Amy J Jak; Yu-Ling Chang; Lisa Delano-Wood; Katherine J Bangen; David P Salmon; Mark W Bondi
Journal:  Neuroimage       Date:  2010-03-16       Impact factor: 6.556

Review 3.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

4.  Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.

Authors:  Kimberly Diggle Mueller; Rebecca L Koscik; Lyn S Turkstra; Sarah K Riedeman; Asenath LaRue; Lindsay R Clark; Bruce Hermann; Mark A Sager; Sterling C Johnson
Journal:  J Alzheimers Dis       Date:  2016-10-18       Impact factor: 4.472

Review 5.  More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration.

Authors:  Courtney Lane-Donovan; Gary T Philips; Joachim Herz
Journal:  Neuron       Date:  2014-08-20       Impact factor: 17.173

Review 6.  Connected speech and language in mild cognitive impairment and Alzheimer's disease: A review of picture description tasks.

Authors:  Kimberly D Mueller; Bruce Hermann; Jonilda Mecollari; Lyn S Turkstra
Journal:  J Clin Exp Neuropsychol       Date:  2018-04-19       Impact factor: 2.475

7.  Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.

Authors:  J T Fuller; A Cronin-Golomb; J R Gatchel; D J Norton; E Guzmán-Vélez; H I L Jacobs; B Hanseeuw; E Pardilla-Delgado; A Artola; A Baena; Y Bocanegra; K S Kosik; K Chen; P N Tariot; K Johnson; R A Sperling; E M Reiman; F Lopera; Y T Quiroz
Journal:  J Prev Alzheimers Dis       Date:  2019

Review 8.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

Authors:  Rhoda Au; Ryan J Piers; Sherral Devine
Journal:  Neuropsychology       Date:  2017-11       Impact factor: 3.295

10.  Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease.

Authors:  Yu-Ling Chang; Mark W Bondi; Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Mark W Jacobson; Anders M Dale
Journal:  Neuropsychologia       Date:  2009-12-23       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.